|
11 Companies |
|
5 Products |
|
5 Products |
|
5 Mechanisms of Action |
|
0 Trials |
|
118 News |
|
| 123» |
- | ProQuad (measles, mumps, rubella and varicella virus vaccine live) / Merck (MSD)
Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date: Safety and Efficacy of ProQuad (clinicaltrials.gov) - Feb 12, 2019
P1, N=5, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | Phase classification: P1/2 --> P1 | N=45 --> 5 | Trial completion date: Dec 2018 --> Nov 2016 | Trial primary completion date: Dec 2018 --> Nov 2016
- | Vaqta (hepatitis A vaccine, inactivated) / Merck (MSD), Varivax (varicella virus vaccine live) / Merck (MSD), ProQuad (measles, mumps, rubella and varicella virus vaccine live) / Merck (MSD)
Phase classification: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) (clinicaltrials.gov) - Feb 4, 2019
P4, N=1800, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed | Phase classification: P1/2 --> P1 | N=45 --> 5 | Trial completion date: Dec 2018 --> Nov 2016 | Trial primary completion date: Dec 2018 --> Nov 2016 Phase classification: P3 --> P4
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Reactivation of Varicella Zoster Virus and Risk of Vascular Disease (clinicaltrials.gov) - Jan 4, 2019
P=N/A, N=0, Withdrawn, Sponsor: University College, London
Phase classification: P3 --> P4 N=2000 --> 0 | Trial completion date: Dec 2017 --> Jan 2019 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Jan 2019
- | Trial completion: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=10, Completed, Sponsor: Mayo Clinic
N=2000 --> 0 | Trial completion date: Dec 2017 --> Jan 2019 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Jan 2019 Active, not recruiting --> Completed
- ||| Zostavax (zoster vaccine live) / Merck (MSD)
Trial completion, IO biomarker: Zoster Vaccine Response in the Frail Elderly (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=241, Completed, Sponsor: McMaster University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial primary completion date: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection (clinicaltrials.gov) - Feb 6, 2018
P=N/A, N=10, Active, not recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Trial primary completion date: Sep 2017 --> Sep 2018
- ||||| ProQuad (measles, mumps, rubella and varicella virus vaccine live) / Merck (MSD)
Enrollment change: Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad (clinicaltrials.gov) - Jan 30, 2018
P3, N=1620, Completed, Sponsor: Merck Sharp & Dohme Corp.
Trial primary completion date: Sep 2017 --> Sep 2018 N=1260 --> 1620
- | Trial completion: Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine (clinicaltrials.gov) - Jan 11, 2018
P=N/A, N=394, Completed, Sponsor: Zhejiang Provincial Center for Disease Control and Prevention
N=1260 --> 1620 Active, not recruiting --> Completed
- ||||||| live attenuated varicella vaccine / Sinovac
Trial completion: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines (clinicaltrials.gov) - Oct 26, 2017
P3, N=5997, Completed, Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| live attenuated varicella vaccine / Sinovac
Trial completion: A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children (clinicaltrials.gov) - Oct 26, 2017
P1, N=270, Completed, Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine. (clinicaltrials.gov) - Jul 26, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed N=50 --> 0 | Initiation date: Oct 2016 --> Apr 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> Apr 2016
- | Trial primary completion date: Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine (clinicaltrials.gov) - Jul 5, 2017
P=N/A, N=360, Active, not recruiting, Sponsor: Zhejiang Provincial Center for Disease Control and Prevention
N=50 --> 0 | Initiation date: Oct 2016 --> Apr 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> Apr 2016 Trial primary completion date: Jan 2017 --> Aug 2017
- Trial completion: Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients (clinicaltrials.gov) - Jun 8, 2017
P3, N=0, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Jan 2017 --> Aug 2017 No longer recruiting --> Completed
- | Trial primary completion date: Reactivation of Varicella Zoster Virus and Risk of Vascular Disease (clinicaltrials.gov) - May 4, 2017
P=N/A, N=2000, Active, not recruiting, Sponsor: University College, London
No longer recruiting --> Completed Trial primary completion date: Dec 2016 --> Dec 2017
- | Zostavax (zoster vaccine live) / Merck (MSD)
Enrollment change, Trial initiation date, Trial primary completion date: T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 (clinicaltrials.gov) - Apr 21, 2017
P4, N=54, Completed, Sponsor: Stanford University
Trial primary completion date: Dec 2016 --> Dec 2017 N=150 --> 54 | Initiation date: Jun 2010 --> Sep 2010 | Trial primary completion date: Dec 2014 --> Dec 2011
- ||| Skyzoster (live attenuated zoster vaccine) / SK Bio
New P1 trial: Safety Study of NBP608 in Healthy Adult Volunteers (clinicaltrials.gov) - Apr 20, 2017
P1, N=150, Completed, Sponsor: SK Chemicals Co.,Ltd.
- ||||| Skyzoster (live attenuated zoster vaccine) / SK Bio
New P2 trial: The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age (clinicaltrials.gov) - Apr 14, 2017
P2, N=152, Completed, Sponsor: SK Chemicals Co.,Ltd.
- ||||||| ProQuad (measles, mumps, rubella and varicella virus vaccine live) / Merck (MSD)
Trial completion: V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) (clinicaltrials.gov) - Apr 11, 2017
P3, N=1027, Completed, Sponsor: Merck Sharp & Dohme Corp.
N=150 --> 54 | Initiation date: Jun 2010 --> Sep 2010 | Trial primary completion date: Dec 2014 --> Dec 2011 No longer recruiting --> Completed
- |||| M-M-RII (measles, mumps, and rubella virus vaccine live) / Merck (MSD)
Trial completion: Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) (clinicaltrials.gov) - Mar 14, 2017
P2, N=1210, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed No longer recruiting --> Completed
- Varivax (varicella virus vaccine live) / Merck (MSD)
Enrollment change, Trial termination: DAIT VZV: Evaluation of the Safety of Varivax (clinicaltrials.gov) - Feb 16, 2017
P1, N=7, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed N=50 --> 7 | Completed --> Terminated; Slow enrollment
- Zostavax (zoster vaccine live) / Merck (MSD)
Enrollment change, Trial termination: Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy (clinicaltrials.gov) - Feb 8, 2017
P4, N=3, Terminated, Sponsor: Innovaderm Research Inc.
N=50 --> 7 | Completed --> Terminated; Slow enrollment N=50 --> 3 | Recruiting --> Terminated; Recruitment difficulties
- Zostavax (zoster vaccine live) / Merck (MSD)
Trial completion: ZOSTAVAX (clinicaltrials.gov) - Jan 9, 2017
P1, N=34, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=50 --> 3 | Recruiting --> Terminated; Recruitment difficulties Terminated --> Completed
- Trial primary completion date: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection (clinicaltrials.gov) - Dec 21, 2016
P=N/A, N=10, Active, not recruiting, Sponsor: Mayo Clinic
Terminated --> Completed Trial primary completion date: Sep 2016 --> Sep 2017
- New trial: Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine (clinicaltrials.gov) - Dec 6, 2016
P=N/A, N=360, Active, not recruiting, Sponsor: Zhejiang Provincial Center for Disease Control and Prevention
- |||||||||| live attenuated varicella vaccine / Sinovac
New P3 trial: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines (clinicaltrials.gov) - Dec 5, 2016
P3, N=5997, Active, not recruiting, Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
- ||| live attenuated varicella vaccine / Sinovac
New P1 trial: A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children (clinicaltrials.gov) - Nov 16, 2016
P1, N=270, Active, not recruiting, Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Varilrix (live attenuated varicella zoster virus vaccine) / GSK
Phase classification, Post-transplantation: Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). (clinicaltrials.gov) - Nov 4, 2016
P3, N=45, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Sep 2016 --> Sep 2017 Phase classification: P2 --> P3
- measles vaccine / Generic mfg.
Trial completion: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases (clinicaltrials.gov) - Sep 25, 2016
P3, N=0, Completed, Sponsor: GlaxoSmithKline
Phase classification: P2 --> P3 No longer recruiting --> Completed
- ||||||| measles vaccine / Generic mfg.
Trial completion: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases (clinicaltrials.gov) - Sep 20, 2016
P3, N=944, Completed, Sponsor: GlaxoSmithKline
No longer recruiting --> Completed Recruiting --> Completed
- |||| Trial completion: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases (clinicaltrials.gov) - Sep 20, 2016
P4, N=1439, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Recruiting --> Completed
- | Zostavax (zoster vaccine live) / Merck (MSD)
Enrollment open, Trial initiation date, Trial primary completion date: Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy (clinicaltrials.gov) - Aug 30, 2016
P4, N=50, Recruiting, Sponsor: Innovaderm Research Inc.
Recruiting --> Completed Suspended --> Recruiting | Initiation date: Oct 2016 --> Jun 2016 | Trial primary completion date: May 2017 --> Jan 2017
- Trial initiation date: Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine. (clinicaltrials.gov) - Aug 26, 2016
P=N/A, N=50, Not yet recruiting, Sponsor: University of Colorado, Denver
Suspended --> Recruiting | Initiation date: Oct 2016 --> Jun 2016 | Trial primary completion date: May 2017 --> Jan 2017 Initiation date: Jul 2016 --> Oct 2016
- ||||||| Trial completion: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. (clinicaltrials.gov) - Jul 12, 2016
P3, N=1560, Completed, Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Initiation date: Jul 2016 --> Oct 2016 Recruiting --> Completed
- New trial, Review: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin (clinicaltrials.gov) - Mar 22, 2016
P=N/A, N=1000, Completed, Sponsor: The Center for the Biology of Chronic Disease
- ||||||| Zostavax (zoster vaccine live) / Merck (MSD)
Trial completion: A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) (clinicaltrials.gov) - Feb 27, 2016
P3, N=368, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed No longer recruiting --> Completed
- ||||||| Zostavax (zoster vaccine live) / Merck (MSD)
Trial completion: Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009) (clinicaltrials.gov) - Feb 27, 2016
P3, N=695, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed No longer recruiting --> Completed
- New trial: Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine. (clinicaltrials.gov) - Feb 25, 2016
P=N/A, N=50, Not yet recruiting, Sponsor: University of Colorado, Denver
- ProQuad (measles, mumps, rubella and varicella virus vaccine live) / Merck (MSD)
New P1/2 trial: Safety and Efficacy of ProQuad (clinicaltrials.gov) - Feb 22, 2016
P1/2, N=45, Recruiting, Sponsor: Medical University of South Carolina
- Trial primary completion date: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=10, Active, not recruiting, Sponsor: Mayo Clinic
No longer recruiting --> Completed Trial primary completion date: Sep 2015 --> Sep 2016
- || Zostavax (zoster vaccine live) / Merck (MSD)
Trial primary completion date, IO biomarker: Zoster Vaccine Response in the Frail Elderly (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=250, Active, not recruiting, Sponsor: McMaster University
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Zostavax (zoster vaccine live) / Merck (MSD)
Trial termination, Trial primary completion date: ZOSTAVAX (clinicaltrials.gov) - Oct 22, 2015
P1, N=34, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Feb 2015
- ||||||| M-M-RII (measles, mumps, and rubella virus vaccine live) / Merck (MSD)
Trial completion: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) (clinicaltrials.gov) - Oct 22, 2015
P3, N=1997, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Feb 2015 No longer recruiting --> Completed
- ||||||| Varivax (varicella virus vaccine live) / Merck (MSD)
Trial completion: Evaluation of Immunogenicity and Safety of VARIVAX (clinicaltrials.gov) - Oct 21, 2015
P3, N=611, Completed, Sponsor: Merck Sharp & Dohme Corp.
No longer recruiting --> Completed Active, not recruiting --> Completed
- New trial: Reactivation of Varicella Zoster Virus and Risk of Vascular Disease (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=2000, Active, not recruiting, Sponsor: University College, London
- | Barycela (varicella II vaccine) / GC Biopharma
Trial completion: Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults (clinicaltrials.gov) - Sep 3, 2015
P1, N=39, Completed, Sponsor: Green Cross Corporation
Active, not recruiting --> Completed Not yet recruiting --> Completed
- ||||||| Zostavax (zoster vaccine live) / Merck (MSD)
Trial completion: Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029) (clinicaltrials.gov) - Jul 17, 2015
P3, N=600, Completed, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Completed Active, not recruiting --> Completed
- Zostavax (zoster vaccine live) / Merck (MSD)
Trial initiation date, Trial suspension, Trial primary completion date: Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy (clinicaltrials.gov) - Jun 11, 2015
P4, N=50, Suspended, Sponsor: Innovaderm Research Inc.
Active, not recruiting --> Completed Initiation date: May 2015 --> Oct 2016 | Not yet recruiting --> Suspended | Trial primary completion date: Dec 2015 --> May 2017
- New trial, Review: Review of Human Herpes Viruses in Burns (clinicaltrials.gov) - May 22, 2015
P=N/A, N=10267, Completed, Sponsor: The University of Texas Medical Branch, Galveston
- ||| New trial: CIzQIDS: Comparison of Immunization Quality Improvement Dissemination Study (clinicaltrials.gov) - May 4, 2015
P=N/A, N=2186, Completed, Sponsor: Children's Research Institute
- Trial primary completion date: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: Mayo Clinic
Initiation date: May 2015 --> Oct 2016 | Not yet recruiting --> Suspended | Trial primary completion date: Dec 2015 --> May 2017 Trial primary completion date: Sep 2014 --> Sep 2015